Cargando…
Predictive performances of lipid accumulation product vs. adiposity measures for cardiovascular diseases and all-cause mortality, 8.6-year follow-up: Tehran lipid and glucose study
BACKGROUND: The body mass index (BMI) is the most commonly used marker for evaluating obesity related risks, however, central obesity measures have been proposed to be more informative. Lipid accumulation product (LAP) is an alternative continuous index of lipid accumulation. We sought in this study...
Autores principales: | Bozorgmanesh, Mohammadreza, Hadaegh, Farzad, Azizi, Fereidoun |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2949857/ https://www.ncbi.nlm.nih.gov/pubmed/20846382 http://dx.doi.org/10.1186/1476-511X-9-100 |
Ejemplares similares
-
Diabetes prediction, lipid accumulation product, and adiposity measures; 6-year follow-up: Tehran lipid and glucose study
por: Bozorgmanesh, Mohammadreza, et al.
Publicado: (2010) -
Prognostic significance of the Complex "Visceral Adiposity Index" vs. simple anthropometric measures: Tehran lipid and glucose study
por: Mohammadreza, Bozorgmanesh, et al.
Publicado: (2012) -
Beta-Cell Age Calculator, a Translational Yardstick to Communicate Diabetes Risk with Patients: Tehran Lipid and Glucose Study
por: Bozorgmanesh, Mohammadreza, et al.
Publicado: (2012) -
Diabetes Mellitus: Findings from 20 Years of the Tehran Lipid and Glucose Study
por: Ramezankhani, Azra, et al.
Publicado: (2018) -
Risk Factors for Incidence of Cardiovascular Diseases and All-Cause Mortality in a Middle Eastern Population over a Decade Follow-up: Tehran Lipid and Glucose Study
por: Sardarinia, Mahsa, et al.
Publicado: (2016)